-
March 19, 2021 Psychedelic Business News Spotlight: March 19, 2021This week in psychedelic business news, quick dissolve LSD, novel psychedelic molecules move into investigational...
-
March 19, 2021 These 24 Psychedelic Patents Are Paving the Way for Medicine 2.0Patents of psychedelic substances are paving the way for new research and treatment options for...
-
March 18, 2021 Researchers to Hone In On Most Therapeutic Doses of LSDNew research is looking into the optimal dose of LSD to further enhance the therapeutic...
-
March 18, 2021 Oregon Announces Creation of the Psilocybin Advisory BoardThe first state to legalize therapeutic use of psilocybin, Oregon now has an advisory board...
-
March 18, 2021 Psychotherapist Kelli Foulkrod Takes a Holistic Approach to Trauma Treatment With PsychedelicsPsychotherapist Kelli Foulkrod uses psychedelics with her patients as part of her holistic treatment to...
-
March 17, 2021 New York Bill Would Decriminalize PsilocybinProposed legislation in the state of New York would decriminalize psilocybin, the psychedelic compound in...
-
March 17, 2021 Psychedelics Officially Decriminalized In Washington D.C.After voters approved a measure that decriminalized psychedelics in Washington D.C. last November, the measure...
-
March 16, 2021 Silo Wellness Ketamine Retreats to Focus on Healing Power of NatureSilo Wellness Inc., a wellness company in the psychedelics and functional mushroom space, is offering...
-
March 16, 2021 U.K. Psychedelic R&D Company Investigates MDMA, Ketamine for AddictionAwakn Life Sciences is looking at psychedelics for addiction, namely MDMA and ketamine for alcohol...
-
March 15, 2021 Small Pharma Clinical Trials to Study DMT for Treatment-Resistant DepressionSmall Pharma is going into clinical trials to look at DMT for depression relief. The...
